Drug reference

tucatinib

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1338

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(too-ka′ti-nib) Tukysa

PDF page 1338

Functional class

Func. class.: Antineoplastic

PDF page 1338

Uses

USES: Breast cancer, human epider mal growth factor receptor 2 positive, advanced unresectable/metastatic

PDF page 1338

Safety

Contraindications

CONTRAINDICATIONS: Hypersensitivity, pregnancy, breastfeeding

PDF page 1338

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: PO 300 mg bid with trastuzumab and capecitabine until disease progres- sion or unacceptable toxicity

PDF page 1338

Available forms

Available forms: Tablet 50, 150 mg

PDF page 1338

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

tucatinib

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1338

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(too-ka′ti-nib) Tukysa

PDF page 1338

Functional class

Func. class.: Antineoplastic

PDF page 1338

Uses

USES: Breast cancer, human epider mal growth factor receptor 2 positive, advanced unresectable/metastatic

PDF page 1338

Safety

Contraindications

CONTRAINDICATIONS: Hypersensitivity, pregnancy, breastfeeding

PDF page 1338

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: PO 300 mg bid with trastuzumab and capecitabine until disease progres- sion or unacceptable toxicity

PDF page 1338

Available forms

Available forms: Tablet 50, 150 mg

PDF page 1338

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.